Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Leg Heat Therapy in Peripheral Artery Disease

NCT: NCT05465070 · RECRUITING

NCT IDNCT05465070
StatusRECRUITING
Start Date2022-11-07
Completion2026-12-31
SponsorIndiana University (OTHER)
First posted
Last updated

Brief Summary

The goal of this randomized, double-blind, sham-controlled clinical trial is to evaluate the benefits of home-based, leg heat therapy (HT) on lower-extremity functioning and quality of life in patients who suffer from lower-extremity peripheral artery disease (PAD). We will randomize 106 patients to one of two groups that either receive leg HT or a sham intervention. The primary study outcome is the change in 6-minute walk distance between baseline and the 12-week follow up. Secondary outcomes include changes in the short physical performance battery score, handgrip strength, quality of life (measured by the Walking Impairment Questionnaire and Short-Form (SF)-36 Questionnaire), calf muscle strength (measured using a calf ergometer), size (measured by magnetic resonance imaging) and bioenergetics (assessed using phosphorus-31 magnetic resonance spectroscopy), and physical activity (measured by accelerometer).

Frequently Asked Questions

What is Leg Heat Therapy in Peripheral Artery Disease?

Leg Heat Therapy in Peripheral Artery Disease is a clinical trial registered under NCT05465070. Current status: RECRUITING.

What is the status of NCT05465070?

The current status of NCT05465070 (Leg Heat Therapy in Peripheral Artery Disease) is: RECRUITING.

When did Leg Heat Therapy in Peripheral Artery Disease start?

Leg Heat Therapy in Peripheral Artery Disease started on 2022-11-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.